Tag Archives: Remdesivir

Gilead’s remdesivir, shown to hasten COVID-19 recovery, cleared for emergency use by FDA

The Food and Drug Administration on Friday cleared an experimental drug from Gilead for emergency use in treating COVID-19, acting quickly following announcement on Wednesday of encouraging results from a crucial government-run study. Results from the study, which was led by the National Institutes for Allergy and Infectious Diseases, showed treatment with remdesivir led to… Read More »

WHO says it will engage US to make remdesivir coronavirus treatment more widely available

World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus attends a daily press briefing on COVID-19, the disease caused by the novel coronavirus, at the WHO heardquaters in Geneva on March 11, 2020. Fabrice Coffrini | AFP | Getty Images The World Health Organization said Monday it will speak with the U.S. government and Gilead Sciences on… Read More »

Gilead’s remdesivir scores emergency FDA nod in COVID-19 days after big data reveal

Days after U.S. officials and others reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has given the drug an emergency use authorization. President Donald Trump and Gilead CEO Daniel O’Day made the announcement Friday afternoon at the White House, according to CNBC’s Meg Tirrell. An FDA fact sheet on the… Read More »

Trending Clinical Topic: Remdesivir

What your doctor is reading on Medscape.com: APRIL 24, 2020 — As the COVID-19 pandemic continues, efforts to identify a safe and effective therapy have intensified, leading to this week’s top trending clinical topic. New data on the investigational antiviral drug remdesivir were published April 10 in the New England Journal of Medicine . More than two thirds of… Read More »